definiens: shall mean, with respect to a Licensed Product sold by Bellicum or an Affiliate orSublicensee thereof in a given country, that one or more Third Parties are selling any product for the same indication, which product ( a ) would infringe a Valid Claim of the Licensed Patent Rights Listed in Part I of Schedule A but for theexpiration of those Licensed Patent Rights in that country, ( b ) contains the same or equivalent ( by applicableRegulatory Authority standards ) active pharmaceutical ingredient(s ) as contained in such Licensed Product in suchcountry, and ( c ) sales of such product(s ) represent at least [ … * * * … ] percent([ … *** … ]% ) of the total market share by volume for all sales of such product(s ) and the Licensed Product in suchcountry for any calendar quarter ( as measured by reputable published data for such country, e.g. by reference tomarket share data collected by IMS )